Lipocine Announces Continued Commercialization of TLANDO® through Verity Pharmaceuticals

SALT LAKE CITY, Feb. 2, 2024 /PRNewswire/ -- Lipocine Inc. , a biopharmaceutical company focused on treating Central Nervous System disorders, today announced that commercialization of TLANDO® in...

Related Keywords

United States ,Canada , ,Lipocine Inc ,Prnewswire Lipocine Inc ,Nasdaq ,Gordon Silver ,Drug Administration ,Central Nervous System ,Verity Pharma ,Gordon Silver Limited ,Boxed Warning ,Product Label ,Blood Pressure ,Benign Prostatic Hyperplasia ,Potential Risk ,Prostate Cancer ,Serum Testosterone Concentrations ,Adverse Effects ,Thyroxine Binding Globulin ,May Also Increase Blood Pressure ,Reproductive Potential ,Prescribing Information ,Private Securities Litigation Reform Act ,Markets ,